Promising applications of tumor spheroids and organoids for personalized medicine

Z Gilazieva, A Ponomarev, C Rutland, A Rizvanov… - Cancers, 2020 - mdpi.com
Simple Summary Presently, the investigation of the tumor is carried out using different
models. One of the promising areas is the creation of 3D tumor models, such as spheroids …

Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening

M Millard, I Yakavets, V Zorin… - International journal …, 2017 - Taylor & Francis
The increasing number of publications on the subject shows that nanomedicine is an
attractive field for investigations aiming to considerably improve anticancer chemotherapy …

Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives

SH Kiaie, S Mojarad-Jabali, F Khaleseh… - International journal of …, 2020 - Elsevier
Abstract Evaluation of axial properties including preparation, surface functionalization, and
pharmacokinetics for delivery of pharmacologically active molecules and genes lead to …

Nano-delivery systems for encapsulation of dietary polyphenols: An experimental approach for neurodegenerative diseases and brain tumors

T Squillaro, A Cimini, G Peluso, A Giordano… - Biochemical …, 2018 - Elsevier
Neurodegenerative diseases (NDs) and brain tumors are severe, disabling, and incurable
disorders that represent a critical problem regarding human suffering and the economic …

Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide

M Mashreghi, M Faal Maleki, M Karimi… - Journal of drug …, 2021 - Taylor & Francis
The aim of this study was to surface-functionalize PEGylated liposomal doxorubicin (PLD)
using anti-p32 CGKRK peptide to evaluate its anti-angiogenic and anti-tumour activities …

Kinetics of Nanomedicine in Tumor Spheroid as an In Vitro Model System for Efficient Tumor-Targeted Drug Delivery With Insights From Mathematical Models

SM Roy, V Garg, S Barman, C Ghosh… - … in Bioengineering and …, 2021 - frontiersin.org
Numerous strategies have been developed to treat cancer conventionally. Most importantly,
chemotherapy shows its huge promise as a better treatment modality over others …

Ligand decorated biodegradable nanomedicine in the treatment of cancer

E Ahmad, A Ali, MT Fatima, A Kumar, MP Sumi… - Pharmacological …, 2021 - Elsevier
Cancer is one of the major global health problems, responsible for the second-highest
number of deaths. The genetic and epigenetic changes in the oncogenes or tumor …

Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy

M Hou, YE Gao, X Shi, S Bai, X Ma, B Li, B **ao, P Xue… - Acta Biomaterialia, 2018 - Elsevier
The goal of nanomedicine is to seek strategies that are more efficient to address various
limitations and challenges faced by conventional medicines, including lack of target …

Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs

D van den Brand, LF Massuger, R Brock… - Bioconjugate …, 2017 - ACS Publications
Macromolecular drug candidates and nanoparticles are typically tested in 2D cancer cell
culture models, which are often directly followed by in vivo animal studies. The majority of …

Control of liposomal penetration into three-dimensional multicellular tumor spheroids by modulating liposomal membrane rigidity

Y Takechi-Haraya, Y Goda… - Molecular …, 2017 - ACS Publications
Effective penetration of drug-carrying nanoparticles into solid tumors is a major challenge in
cancer therapy. Exploration of the physicochemical properties of nanoparticles that affect …